Skip to main content
Skip to main content
EVKIY logo

Evonik Industries AG (EVKIY) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$10.54 +$0.02 (+0.19%) |CouncilBullish Lean · 60 · B+
MCap: $9.82B| P/E Ratio: 69.06| Vol: 100| 52-wk range: $7.24 – $11.03

P/E 69.06 means the share price is 69.06 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $9.82B is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Evonik Industries AG (EVKIY) trades at $10.54. Evonik Industries AG is a German specialty chemicals company operating globally across five key segments, including Specialty Additives, Nutrition & Care, and Smart Materials. Market cap: $9.82B, Sector: Basic materials.

Price as of Sep 11, 2026 · Last analyzed: Jun 15, 2026
Evonik Industries AG is a German specialty chemicals company operating globally across five key segments, including Specialty Additives, Nutrition & Care, and Smart Materials. The company provides a diverse range of advanced chemical compounds and materials essential for consumer products, animal nutrition, healthcare, and various industrial applications like automotive and construction.

Analyst Coverage for EVKIY: EVKIY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates EVKIY against Basic Materials peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the EVKIY film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 12 months ago — the most recent this company has published.

No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.

Council Score · Weighted Average of 3 Disciplines
Bullish Lean 60/100 · B+

EVKIY: 1/2 scored disciplines lean bullish. Dominant signal: Seth Klarman bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Englander-style lens (simulated)Izzy Englander
Favorable read
Klarman-style lens (simulated)Seth Klarman
Favorable read
Moon AI lens (model)
Favorable read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Evonik Industries AG (EVKIY) Materials & Commodity Exposure

CEOChristian Kullmann
Employees31,053
HeadquartersEssen, DE
IPO Year2021

Evonik Industries AG, a German specialty chemicals producer established in 1873, operates globally across five segments including Specialty Additives and Nutrition & Care. It supplies crucial compounds for diverse applications from consumer products to automotive, leveraging a diversified portfolio to serve various industrial and life science markets worldwide.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 15, 2026

What Is the Investment Thesis for EVKIY?

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

Evonik Industries AG presents a diversified investment profile within the specialty chemicals sector, underpinned by its broad product portfolio and global operational footprint. With a market capitalization of $9.82B, the company demonstrates significant scale. The company's diversified product offerings across five segments, including Specialty Additives and Nutrition & Care, mitigate risk by reducing reliance on any single end market, a key strength highlighted by its focus on animal feed additives and the automotive industry. Future growth catalysts include ongoing innovation in life science ingredients and advanced materials, particularly for high-growth sectors like healthcare and sustainable technologies. The company's global reach across Asia-Pacific, Europe, and the Americas provides avenues for market expansion and increased revenue generation, positioning Evonik to capitalize on evolving industrial demands and regional economic growth.

Based on FMP financials and quantitative analysis

EVKIY Key Highlights

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

Market Capitalization: $9.82B, reflecting its significant presence and scale within the global specialty chemicals sector.

  • P/E Ratio: 69.06, indicating a higher valuation multiple that may suggest investor confidence in its future earnings potential and specialized market positioning.
  • Profit Margin: 1.1%, demonstrating the company's net profitability after all expenses, which is relatively tight within its complex operational structure.
  • Gross Margin: 22.6%, showcasing the company's ability to maintain a solid margin on its specialized chemical products before operating expenses.
  • Dividend Yield: 6.37%, offering a substantial return to shareholders, which can be particularly appealing for income-focused institutional investors.

Who Are EVKIY's Competitors?

EVKIY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
NDEKY Nitto Denko Corporation $20.45 +0.05% $13.8B 439-signal
MMLTF MMG Limited $1.20 0.00% $15.4B
BNTGF Brenntag SE $69.00 0.00% $9.96B 449-signal
ASGLY AGC Inc. $7.02 -1.96% $7.46B
MTLHY Mitsubishi Chemical Group Corporation $37.05 0.00% $10.1B
SOLS SOLS $61.63 +0.11% $9.79B 545-pillar
SSL Sasol Limited $14.54 -0.75% $9.27B 975-pillar
AKZOF Akzo Nobel N.V. $67.41 -2.74% $11.5B 449-signal

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are EVKIY's Key Strengths?

Highly diversified product portfolio across five distinct business segments, mitigating market-specific risks.

  • Strong global operational footprint, enabling broad market reach and regional adaptability.
  • Specialization in high-value, performance-driven chemical compounds and life science ingredients.
  • Established presence in key growth markets such as animal feed additives and the automotive industry.
  • Robust gross margin of 22.6% indicating strong pricing power for its specialized products.

What Are EVKIY's Weaknesses?

Modest profit margin of 1.1%, suggesting potential for operational inefficiencies or high cost structures.

  • Reliance on the broader economic health of industrial sectors, which can be cyclical.
  • Exposure to raw material price volatility, common in the basic materials sector.
  • As an ADR, potential for lower liquidity and less stringent reporting requirements compared to major exchanges.
  • Currency exchange rate fluctuations can impact financial results for ADR holders.

What Could Drive EVKIY Stock Higher?

EVKIY catalyst: **Innovation in Sustainable Chemistry**: Continued investment and breakthroughs in green chemistry solutions, such as advanced catalysts for renewable energy or bio-based materials, could open new market segments and enhance Evonik's competitive position, driving revenue growth.

  • **Global Economic Recovery and Industrial Demand**: A sustained recovery in global industrial production, particularly in the automotive, construction, and consumer goods sectors, would directly increase demand for Evonik's specialty chemicals and materials.
  • **Strategic Partnerships and Acquisitions**: Any strategic partnerships or targeted acquisitions in high-growth areas like life sciences or advanced materials could expand Evonik's product portfolio, market share, and operational synergies.
  • **Expansion in Emerging Markets**: Successful execution of market penetration strategies in rapidly developing economies, particularly in Asia-Pacific and Latin America, could unlock significant new revenue streams for the company.
  • **Demand for Animal Nutrition and Healthcare Ingredients**: Persistent global demand for high-quality animal nutrition products and pharmaceutical-grade ingredients will continue to support the growth of Evonik's Nutrition & Care segment.

What Are the Key Risks for EVKIY?

Rich valuation — a P/E of 69.06 runs well above the Basic Materials sector’s ~21.40x, leaving little room for a miss.

  • **Economic Downturns and Industrial Cyclicality**: A significant slowdown in global economic growth or specific industrial sectors (e.g., automotive, construction) could reduce demand for Evonik's specialty chemicals, impacting revenues and profitability.
  • **Raw Material Price Volatility**: Fluctuations in the cost of key raw materials, often linked to global commodity markets and energy prices, can compress Evonik's profit margins if these increases cannot be fully passed on to customers.
  • **Regulatory and Environmental Compliance**: Increasingly stringent environmental regulations and compliance costs, particularly in Europe, could lead to higher operational expenses or require significant investments in new production technologies.
  • **Currency Exchange Rate Fluctuations**: As an ADR, EVKIY is exposed to volatility in the EUR/USD exchange rate, which can negatively affect the U.S. dollar value of its earnings and dividends for U.S. investors.
  • **Competitive Pressures and Innovation**: Intense competition within the specialty chemicals industry, coupled with the need for continuous innovation, poses a risk if Evonik fails to keep pace with technological advancements or market demands, potentially leading to market share erosion.

What Are the Growth Opportunities for EVKIY?

  • Growth opportunity 1: **Expansion in Life Science Ingredients**: The Nutrition & Care segment, which provides life science ingredients such as amino acids, ceramides, and pharmaceutical-grade polymers, is poised for growth. As global populations age and demand for health-conscious consumer goods and advanced healthcare solutions increases, the market for these specialized ingredients is expanding. Evonik's expertise in developing high-purity, functional ingredients positions it to capture a larger share of this market, which is driven by long-term demographic shifts and rising health awareness. This segment's growth trajectory is expected to continue for the foreseeable future, supported by ongoing R&D in biotechnology and nutrition.
  • Growth opportunity 2: **Advanced Materials for Automotive and Lightweighting**: Evonik's Smart Materials segment offers cutting-edge products like PEEK (polyether ether ketone) and polyamide 12, which are crucial for lightweighting and performance enhancement in the automotive industry. With the ongoing shift towards electric vehicles and stricter emission standards, there is a growing demand for advanced, lighter-weight materials that improve fuel efficiency and battery range. Evonik's specialized polymers and catalysts cater directly to these trends, providing a significant growth avenue as the automotive sector continues its transformation. This opportunity is ongoing, with substantial market potential over the next decade as vehicle electrification accelerates.
  • Growth opportunity 3: **Specialty Additives for Sustainable Consumer Products**: The Specialty Additives division supplies a variety of advanced compounds, including organically modified silicones and acetylenic diol-based surfactants, which are vital for consumer products. As consumers increasingly demand more sustainable and high-performance personal care, home care, and industrial cleaning products, the market for specialized, eco-friendly additives is expanding. Evonik's ability to innovate in this space, offering solutions that enhance product efficacy while meeting environmental standards, positions it for sustained growth. This trend is ongoing, with market demand for sustainable solutions expected to intensify over the next five to ten years.
  • Growth opportunity 4: **Catalysts for Green Technologies and Industrial Processes**: Evonik's Smart Materials segment includes a diverse array of catalysts, such as activated nickel and precious metal powder catalysts, which are essential for various industrial processes, including oil and fat hydrogenation and emerging green technologies. The global push towards more efficient and environmentally friendly chemical production processes, including those for renewable fuels and sustainable polymers, creates a robust demand for advanced catalysts. Evonik's R&D in catalyst technology allows it to develop solutions that improve process efficiency and reduce environmental impact, tapping into a growing market for sustainable industrial solutions. This is an ongoing opportunity, driven by global decarbonization efforts.
  • Growth opportunity 5: **Leveraging Global Operational Footprint in Emerging Markets**: Evonik maintains a global operational footprint across Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. This extensive reach allows the company to capitalize on industrialization and economic growth in emerging markets. As these regions develop, demand for specialty chemicals in construction, automotive, consumer goods, and infrastructure projects increases. By strategically expanding its sales and distribution networks and tailoring products to regional needs, Evonik can deepen its market penetration and capture new revenue streams from these rapidly growing economies. This is an ongoing, long-term growth driver.

What Threats Does EVKIY Face?

  • Intense competition from other global specialty chemical manufacturers.
  • Stringent and evolving environmental regulations impacting production costs and product formulations.
  • Economic downturns or geopolitical instability affecting global industrial output and demand for chemicals.
  • Technological disruptions or new material innovations from competitors that could displace existing products.
  • Supply chain disruptions or increased costs for critical raw materials.

What Are EVKIY's Competitive Advantages?

  • **Diversified Product Portfolio**: A broad range of specialized chemical compounds across five segments mitigates risk and caters to diverse, stable end markets.
  • **Technological Expertise and R&D**: Deep knowledge in chemical synthesis and materials science allows for the development of high-performance, proprietary products.
  • **Global Operational Footprint**: Extensive manufacturing and distribution capabilities across multiple continents provide broad market access and regional resilience.
  • **Customer Integration**: Supplying critical ingredients and materials often leads to deep integration with customer supply chains, creating switching costs.
  • **Regulatory Compliance and Specialization**: Expertise in producing materials that meet stringent industry and regulatory standards, particularly in life sciences and automotive, creates barriers to entry.

What Does EVKIY Do?

Evonik Industries AG, founded in 1873 and headquartered in Essen, Germany, has evolved into a global powerhouse in specialty chemical production, operating as a subsidiary of the RAG-Stiftung. The company's extensive operations are strategically segmented into five principal divisions: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure. The Specialty Additives division is a critical supplier of advanced chemical compounds, encompassing polyurethane enhancers, organically modified silicones, isophorones, epoxy curing agents, oil performance additives, fumed silicas, matting agents, TAA derivatives, and acetylenic diol-based surfactants. These products are indispensable for a broad spectrum of consumer goods and specialized industrial uses. The Nutrition & Care segment is dedicated to life science ingredients, offering amphoteric surfactants, ceramides, phytosphingosines, oleochemical compounds, quaternary derivatives, various amino acids, synthesis products, pharmaceutical-grade polymers, and DL-methionine. These components are vital for consumer goods, animal nutrition, and the healthcare sector. Under its Smart Materials umbrella, Evonik delivers cutting-edge materials such as hydrogen peroxide, peracetic acid, a diverse array of catalysts (including activated nickel and precious metal powder), amorphous polyalphaolefins, polybutadienes, various resins (polyester, thermoplastic, and reactive methacrylate), PEEK, polyamide 12, organosilanes, chlorosilanes, fumed silicas, fumed metal oxides, and precipitated silicas. These materials find application across numerous industries, including automotive, paints, coatings, adhesives, and construction. The Performance Materials segment focuses on essential polymer materials and chemical intermediates like butene-1, DINP, isononanol, cyanuric chloride, alkoxides, and superabsorbent polymers, serving the rubber, plastics, and automotive industries. Finally, the Technology & Infrastructure division provides crucial internal services, including site management, utility and waste handling, technical support, process technology development, engineering, and logistics solutions, ensuring the smooth operation of Evonik's global facilities. The company maintains a significant international presence, conducting business across the Asia-Pacific region, Europe, the Middle East, Africa, Central and South America, and North America, underscoring its expansive global reach and diversified market engagement.

What Products and Services Does EVKIY Offer?

  • Produce specialty additives like polyurethane enhancers, silicones, and epoxy curing agents for consumer and industrial applications.
  • Develop life science ingredients such as amino acids, ceramides, and pharmaceutical-grade polymers for nutrition and healthcare.
  • Manufacture smart materials including hydrogen peroxide, catalysts, PEEK, and polyamide 12 for automotive, construction, and coatings.
  • Create performance materials like butene-1, DINP, and superabsorbent polymers for the rubber, plastics, and automotive industries.
  • Provide essential technology and infrastructure services, including site management, utilities, and engineering support, for its own operations.
  • Operate globally, serving markets across Asia-Pacific, Europe, the Americas, and Africa.
  • Focus on high-value, performance-driven chemical compounds rather than commodity chemicals.

How Does EVKIY Make Money?

  • Develops, produces, and sells a wide range of specialized chemical products and materials to industrial customers globally.
  • Generates revenue through the sale of advanced chemical compounds, life science ingredients, and performance materials across diverse end markets.
  • Offers integrated services, including site management and technical support, primarily for its internal operations, optimizing efficiency.
  • Invests in research and development to innovate new products and improve existing ones, maintaining a competitive edge in specialty markets.
  • Leverages a global production and distribution network to serve customers across multiple continents, ensuring broad market access.

What Industry Does EVKIY Operate In?

Evonik Industries AG operates within the highly specialized and competitive Chemicals - Specialty industry, a segment of the broader Basic Materials sector. This industry is characterized by a focus on high-value, performance-driven chemical products tailored for specific applications, rather than commodity chemicals. Evonik's position is strengthened by its diversified portfolio across five distinct business segments, which allows it to serve a wide array of end markets, including automotive, construction, consumer goods, animal nutrition, and healthcare. The industry is currently experiencing trends towards sustainability, digitalization, and the development of advanced materials, where Evonik's Smart Materials and Nutrition & Care segments are particularly well-positioned. Key competitive factors include R&D capabilities, product innovation, global distribution networks, and the ability to meet stringent regulatory requirements. Evonik's established global operational footprint and specialized product offerings provide a competitive edge against peers by enabling it to cater to diverse regional demands and niche market needs effectively.

Who Are EVKIY's Key Customers?

  • Manufacturers in the automotive industry requiring advanced polymers and catalysts for lightweighting and performance.
  • Companies in the consumer goods sector seeking specialty additives for personal care, home care, and industrial cleaning products.
  • Pharmaceutical and healthcare companies utilizing life science ingredients for drug formulations and medical devices.
  • Animal nutrition companies sourcing amino acids and other feed additives for livestock and aquaculture.
  • Construction, paints, coatings, and adhesives industries needing specialized resins, silicas, and other materials.
Model self-rating on this text: 74% (not a measure of the evidence) Updated: Jun 15, 2026

Research confidence

Medium 45/100

Enough evidence to be useful, with gaps worth knowing about.

  • Scoring coverage unknown
  • Price is current
  • Latest filing 73 days ago
  • No analyst coverage
  • Reported in EUR, converted to USD

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 39
2026-08-26 39
2026-08-29 39
2026-09-01 39
2026-09-04 39
2026-09-07 39
2026-09-10 39

What changed?

The score has stayed at 39.

Over the same 18 days the stock moved -1.1%.

Company Profile

Evonik Industries AG operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Essen, DE. The company is led by CEO Christian Kullmann. EVKIY has traded publicly since 2021.

ROE 2%

Key Financial Metrics

Return on equity for Evonik Industries AG stands at 1.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.9%, showing how much profit it generates from its asset base. EVKIY trades at a trailing price-to-earnings ratio of 69.06, above the Basic Materials sector average of ~21.40x. Its free cash flow yield is 8.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.51 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.1%, the inverse of the P/E and a quick read on earnings relative to price.

EVKIY Valuation & Market Position

With a $9.82B market cap, Evonik Industries AG sits in the mid-cap segment of the market.

Quarterly Financial Performance: Evonik Industries AG

Revenue for Evonik Industries AG came in at $4.52B during Q2 FY2026, a 13.6% improvement versus the preceding quarter. The company recorded net income of $97.5M, with diluted EPS of $0.10. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this mid-cap Basic Materials company. Across the four most recent quarters, EVKIY averaged $0.04 in diluted EPS.

F-Score 6/9

Financial Health

Evonik Industries AG's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.95 places it in the grey zone, a middle ground that warrants monitoring.

EVKIY Financials

Fundamental Snapshot

Revenue Growth (FY)
-7.2%
Net Income Growth (FY)
+19.4%
EPS Growth (FY)
+16.7%
Free Cash Flow Growth (FY)
-20.4%
P/E (TTM)
69.06
Return on Equity (TTM)
+1.9%
Current Ratio
1.5
EV/EBITDA (TTM)
6.2

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Highly diversified product portfolio across five distinct business segments, mitigating market-specific risks.
  • Strong global operational footprint, enabling broad market reach and regional adaptability.
  • Specialization in high-value, performance-driven chemical compounds and life science ingredients.
  • Established presence in key growth markets such as animal feed additives and the automotive industry.

Bear Case

  • Modest profit margin of 1.1%, suggesting potential for operational inefficiencies or high cost structures.
  • Reliance on the broader economic health of industrial sectors, which can be cyclical.
  • Exposure to raw material price volatility, common in the basic materials sector.
  • As an ADR, potential for lower liquidity and less stringent reporting requirements compared to major exchanges.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 FY2026 $4.52B $97M $0.10
Q1 FY2026 $3.98B $145M $0.16
Q4 FY2025 $3.95B $21M $0.02
Q3 FY2025 $3.93B -$123M -$0.13

Q2 FY2026 · filed 30 Jun 2026 · Financial Modeling Prep

Based on FMP financials and quantitative analysis · Converted to USD from EUR at today's rate

EVKIY Latest News

EVKIY Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for EVKIY.

Price Targets

Wall Street price target analysis for EVKIY.

EVKIY MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for EVKIY; grades run from A+ (80-100) to F (below 30).

Leadership: Christian Kullmann

Chairman of the Executive Board and CEO

Christian Kullmann has a distinguished career in corporate leadership and finance. Prior to his role as CEO of Evonik Industries AG, he served as Chief Financial Officer of the company, demonstrating a deep understanding of its financial operations and strategic direction. His career has included various leadership positions within the RAG Group, Evonik's parent company, providing him with extensive experience in complex industrial environments and corporate governance. He holds a strong background in managing large-scale organizations and navigating the intricacies of the global chemical industry.

Track Record: Under Christian Kullmann's leadership, Evonik Industries AG has focused on strengthening its specialty chemicals portfolio and enhancing operational efficiency. He has overseen strategic initiatives aimed at optimizing the company's business segments and driving innovation, particularly in high-growth areas like life sciences and advanced materials. His tenure has been marked by efforts to adapt the company to evolving market demands and to reinforce its global competitive position, managing a workforce of 31,585 employees.

Evonik Industries AG ADR Information Unsponsored

Evonik Industries AG trades as an American Depositary Receipt (ADR) under the ticker EVKIY. An ADR is a certificate issued by a U.S. bank that represents shares of a foreign stock. This allows U.S. investors to buy shares of Evonik Industries AG in U.S. dollars and trade them on U.S. markets, bypassing the complexities of direct foreign exchange trading. Each EVKIY ADR represents a certain number of underlying shares of Evonik's common stock (EVKI) traded on its home market.

  • Home Market Ticker: The primary stock exchange for Evonik Industries AG (EVKI) is the Frankfurt Stock Exchange (XTRA) in Germany.
  • ADR Level: 1
  • ADR Ratio: 1:1
  • Home Market Ticker: EVKI
Currency Risk: Investing in EVKIY ADRs exposes holders to currency risk, primarily related to the Euro (EUR) to U.S. Dollar (USD) exchange rate. Fluctuations in this rate can impact the value of the ADR and the U.S. dollar equivalent of any dividends paid. If the Euro weakens against the U.S. Dollar, the value of the ADRs in USD terms may decrease, even if the underlying stock price in EUR remains stable or increases. Conversely, a stronger Euro could positively impact the ADR's value for U.S. investors.
Tax Implications: Dividends paid on EVKIY ADRs are typically subject to German withholding tax. The standard German withholding tax rate is 26.375%. However, U.S. investors may be eligible for a reduced rate under the U.S.-Germany tax treaty, often to 15%. Investors would need to claim this reduction through their broker or by filing for a refund with the German tax authorities. It is advisable for investors to consult with a tax advisor regarding specific tax implications.
Trading Hours: Evonik's home market shares (EVKI) trade on the Frankfurt Stock Exchange, which operates during European market hours (typically 9:00 AM to 5:30 PM CET). In contrast, EVKIY ADRs trade on the U.S. OTC market during U.S. trading hours (typically 9:30 AM to 4:00 PM ET). This difference in trading hours means that significant news or events occurring during European market hours may not be immediately reflected in the EVKIY price until U.S. markets open, leading to potential price gaps.

EVKIY OTC Market Information

EVKIY trades on the OTC Other tier of the OTC market, which is the lowest tier for companies that do not meet the minimum financial standards or disclosure requirements for OTCQX or OTCQB. Unlike stocks listed on major exchanges like the NYSE or NASDAQ, OTC stocks are traded directly between parties or through a dealer network, rather than on a centralized exchange. The 'OTC Other' tier means the company may not provide regular financial disclosures to the SEC, or its disclosures may be limited, making it more challenging for investors to access comprehensive financial information. This tier is associated with higher risk due to potentially lower transparency and liquidity.

  • OTC Tier: OTC Other
Liquidity: As an OTC Other tier stock, EVKIY typically experiences lower liquidity compared to stocks traded on major exchanges. Lower liquidity means fewer buyers and sellers, which can lead to wider bid-ask spreads and greater price volatility. Investors may find it more difficult to buy or sell shares quickly without significantly impacting the price. The trading volume can be inconsistent, making large transactions challenging and potentially resulting in unfavorable execution prices, increasing the overall trading difficulty for institutional investors.
OTC Risk Factors:
  • Lower liquidity and wider bid-ask spreads, making it difficult to execute trades efficiently.
  • Less stringent reporting requirements and 'Unknown' disclosure status, leading to limited financial transparency.
  • Increased price volatility due to lower trading volume and fewer market participants.
  • Potential for less analyst coverage and institutional interest compared to exchange-listed stocks.
  • Higher susceptibility to market manipulation due to the less regulated trading environment.
Due Diligence Checklist:
  • Verify the company's financial reports and disclosures from its home market (Germany), if available.
  • Assess the trading volume and bid-ask spread to understand liquidity and potential trading costs.
  • Research the company's business fundamentals, competitive landscape, and industry trends thoroughly.
  • Understand the specific risks associated with Level 1 ADRs and the OTC Other tier.
  • Consult with a financial advisor experienced in international and OTC markets.
  • Monitor currency exchange rates between EUR and USD due to ADR exposure.
  • Evaluate the company's corporate governance practices and management team's track record.
Legitimacy Signals:
  • Evonik Industries AG is a large, established company founded in 1873 with its headquarters in Essen, Germany.
  • It is a subsidiary of the RAG-Stiftung, a reputable German foundation, providing a stable ownership structure.
  • The company has a significant global operational footprint across multiple continents, indicating substantial business operations.
  • Christian Kullmann, a known CEO, leads the company, managing over 31,000 employees.
  • Its core business in specialty chemicals is well-defined and serves diverse, critical industrial sectors.

Common Questions About EVKIY (Basic Materials)

Is EVKIY a good stock?

Stock Expert AI does not rate EVKIY buy, sell or hold. Evonik Industries AG has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What are the main risks for EVKIY?

Evonik Industries AG faces several key risks inherent to its industry and operational structure. As a specialty chemicals producer, it is susceptible to the cyclical nature of industrial demand, meaning economic downturns can significantly impact sales.

What are the key factors to evaluate for EVKIY?

Evaluate EVKIY on fundamentals, analyst consensus, and risk factors. P/E: 69.06x vs the S&P 500's ~20-25x. This trend is ongoing, with market demand for sustainable solutions expected to intensify over the next five to ten years. Not financial advice.

How frequently does EVKIY data refresh on this page?

EVKIY's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven EVKIY's recent stock price performance?

Evonik Industries AG (EVKIY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Highly diversified product portfolio across five distinct business segments, mitigating market-specific risks. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider EVKIY overvalued or undervalued right now?

Evonik Industries AG (EVKIY) trades at 69.06x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of EVKIY?

Yes, most major brokerages offer fractional shares of Evonik Industries AG (EVKIY) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track EVKIY's earnings and financial reports?

Evonik Industries AG (EVKIY) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for EVKIY earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Word counts for several sections were challenging to meet precisely while adhering to content rules; efforts were made to stay within specified ranges.
  • CEO tenureYears could not be determined from the provided data.
  • Disclosure status for OTC is 'Unknown' as per source, which was explicitly stated in the otcAnalysis.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover